The Origimm Biotechnology brand, founded in 2009 (Austria), from 2757 sister brands and 17477 competing brands. Origimm Biotechnology is owned by SANOFI, listed on the stock exchange of Paris The ISIN, the company's International Securities Identification Number, is FR0000120578. Origimm Biotechnology is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
SANOFI
(Origimm Biotechnology)
over 5 years*
EUR 108.21